Literature DB >> 10025798

Alternative therapy use in neurologic diseases: use in brain tumor patients.

M J Verhoef1, N Hagen, G Pelletier, P Forsyth.   

Abstract

BACKGROUND: The extent of alternative therapy use in brain tumor patients is unknown, but it may be frequent and seems important to those who use it.
OBJECTIVE: To characterize alternative therapy use in brain tumor patients.
METHODS: Prospective questionnaire-based survey of 167 brain tumor patients who attended a cancer center in Southern Alberta. Physicians completed forms describing clinical information such as disease status.
RESULTS: The response rate was 91% (167/184). Twenty-four percent of patients used alternative therapies and often more than one therapy at the same time. Motivation to use these therapies was influenced by the desire for patient-focused treatment and a perceived need to take charge. Alternative therapy users were younger (p = 0.04) and more likely to be on sick or disability leave (p = 0.02), to come in for repeat visits (p = 0.05), and to have received conventional treatments (p = 0.01). Users tended to have lower quality of life with respect to physical well-being, functional well-being, and a specific brain tumor subscale. Clinical variables, such as disease status, tumor type, and Karnofsky Performance Score, were not related to alternative therapy use. Major changes in number and types of alternative therapy use occurred during the study period. No major side effects or tumor responses were seen with alternative therapies.
CONCLUSIONS: Alternative therapy use in brain tumor patients is common and may reflect unmet patient needs with respect to their cancer care within the current model of health care delivery.

Entities:  

Mesh:

Year:  1999        PMID: 10025798     DOI: 10.1212/wnl.52.3.617

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  17 in total

Review 1.  Quality, efficacy and safety of complementary medicines: fashions, facts and the future. Part I. Regulation and quality.

Authors:  Joanne Barnes
Journal:  Br J Clin Pharmacol       Date:  2003-03       Impact factor: 4.335

Review 2.  Great expectations: what do patients using complementary and alternative medicine hope for?

Authors:  E Ernst; S K Hung
Journal:  Patient       Date:  2011       Impact factor: 3.883

3.  Use of complementary therapies and non-prescribed medication in patients with Parkinson's disease.

Authors:  P Ferry; M Johnson; P Wallis
Journal:  Postgrad Med J       Date:  2002-10       Impact factor: 2.401

4.  Complementary therapy and support services for formal and informal caregivers in Italian palliative care hospices: an exploratory and descriptive study.

Authors:  Monia Belletti; Luca Mallia; Fabio Lucidi; Simona Reichmann; Chiara Mastroianni; Maria Grazia De Marinis; Giuseppe Casale
Journal:  Support Care Cancer       Date:  2010-11-08       Impact factor: 3.603

Review 5.  The Role of Glucose Modulation and Dietary Supplementation in Patients With Central Nervous System Tumors.

Authors:  Roy E Strowd; Stuart A Grossman
Journal:  Curr Treat Options Oncol       Date:  2015-08

Review 6.  Antiepileptic therapy in patients with central nervous system malignancies.

Authors:  Glen H J Stevens
Journal:  Curr Neurol Neurosci Rep       Date:  2006-07       Impact factor: 5.081

7.  Complementary and alternative medicine use in glioma patients in France.

Authors:  Emilie Le Rhun; Patrick Devos; Véronique Bourg; Amélie Darlix; Véronique Lorgis; Guido Ahle; Mathieu Boone; Luc Taillandier; Elsa Curtit; Louis Gras; Christine Lebrun Frenay; Dorothee Gramatzki; Carole Ramirez; Nicolas Simon; Michael Weller
Journal:  J Neurooncol       Date:  2019-10-21       Impact factor: 4.130

8.  Quality of Life and Patterns of Use of Complementary and Alternative Medicines Among Glioma Patients.

Authors:  Ketty Mobed; Raymond Liu; Susan Stewart; Margaret Wrensch; Lucie McCoy; Terri Rice; Michael Prados; Susan Chang
Journal:  J Support Oncol       Date:  2009 Nov-Dec

9.  Quality of life in brain tumor patients: the relative contributions of depression, fatigue, emotional distress, and existential issues.

Authors:  Guy Pelletier; Marja J Verhoef; Nasreen Khatri; Neil Hagen
Journal:  J Neurooncol       Date:  2002-03       Impact factor: 4.130

10.  Discrepant views of oncologists and cancer patients on complementary/alternative medicine.

Authors:  Mary Ann Richardson; Louise C Mâsse; Kelly Nanny; Christina Sanders
Journal:  Support Care Cancer       Date:  2004-11       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.